跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,881 条关于
“IKT-001”
全部
13,881
临床试验
6,023
药物
5,999
机构
28
资讯
1,831
10个月前
Inhibikase Therapeutics Advances IKT-001 to Global Phase 3 Study for Pulmonary Arterial Hypertension
去年
Inhibikase Therapeutics Secures $275M Financing, Advances IkT-001Pro for Pulmonary Arterial Hypertension
5个月前
Inhibikase Therapeutics Initiates Phase 3 IMPROVE-PAH Trial for Novel Pulmonary Arterial Hypertension Treatment
2年前
Inhibikase Therapeutics Completes Enrollment in Phase 2 Trial for Parkinson's Disease Treatment
去年
Inhibikase Halts Parkinson's Drug Development Following Phase II Trial Setback
7个月前
Pulmonary Arterial Hypertension Pipeline Expands with 55+ Therapies as Merck's WINREVAIR Shows 76% Mortality Risk Reduction
2年前
Neuraptive's NTX-001 Receives FDA Breakthrough Therapy Designation for Peripheral Nerve Injury
去年
Insignis Therapeutics Receives Positive FDA Feedback for Needle-Free Anaphylaxis Treatment, IN-001
去年
CD Biopharma's CD-001 Receives FDA Clearance for Phase 1 Trial in Oncology
去年
Hoth Therapeutics' HT-001 Demonstrates 100% Success in Phase 2a Trial for Cancer Treatment Skin Toxicities
第 1 页,共 184 页
上一页
下一页